Your browser doesn't support javascript.
loading
Preexisting comorbidities shape the immune response associated with severe COVID-19.
Kreutmair, Stefanie; Kauffmann, Manuel; Unger, Susanne; Ingelfinger, Florian; Núñez, Nicolás Gonzalo; Alberti, Chiara; De Feo, Donatella; Krishnarajah, Sinduya; Friebel, Ekaterina; Ulutekin, Can; Babaei, Sepideh; Gaborit, Benjamin; Lutz, Mirjam; Jurado, Nicole Puertas; Malek, Nisar P; Göpel, Siri; Rosenberger, Peter; Häberle, Helene A; Ayoub, Ikram; Al-Hajj, Sally; Claassen, Manfred; Liblau, Roland; Martin-Blondel, Guillaume; Bitzer, Michael; Roquilly, Antoine; Becher, Burkhard.
Afiliação
  • Kreutmair S; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland; German Cancer Consortium and German Cancer Research Center, Heidelberg, Partner Site Freiburg, Freiburg, Germany. Electronic address: kreutmair@immunology.uzh.ch.
  • Kauffmann M; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Unger S; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Ingelfinger F; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Núñez NG; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Alberti C; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • De Feo D; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Krishnarajah S; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Friebel E; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Ulutekin C; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Babaei S; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.
  • Gaborit B; Université de Nantes, CHU Nantes, EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Service d'Anesthésie Réanimation chirurgicale, Hôtel Dieu, Nantes, France.
  • Lutz M; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Jurado NP; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Malek NP; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany; the Center for Personalized Medicine, Eberhard-Karls University, Tuebingen, Germany.
  • Göpel S; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany; the German Centre for Infection Research, Partner Site Tuebingen, Tuebingen, Germany.
  • Rosenberger P; the Department of Anesthesiology and Intensive Care Medicine, Eberhard-Karls University, Tuebingen, Germany.
  • Häberle HA; the Department of Anesthesiology and Intensive Care Medicine, Eberhard-Karls University, Tuebingen, Germany.
  • Ayoub I; Toulouse Institute for Infectious and Inflammatory Diseases, Université de Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Toulouse, France.
  • Al-Hajj S; Toulouse Institute for Infectious and Inflammatory Diseases, Université de Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Toulouse, France.
  • Claassen M; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany.
  • Liblau R; Toulouse Institute for Infectious and Inflammatory Diseases, Université de Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Toulouse, France.
  • Martin-Blondel G; Toulouse Institute for Infectious and Inflammatory Diseases, Université de Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Toulouse, France; Department of Infectious and Tropical Diseases, Toulouse University Hospital, Toulouse, Fran
  • Bitzer M; Department Internal Medicine I, Eberhard-Karls University, Tuebingen, Germany; the Center for Personalized Medicine, Eberhard-Karls University, Tuebingen, Germany.
  • Roquilly A; Université de Nantes, CHU Nantes, EA3826 Thérapeutiques Anti-Infectieuses, Institut de Recherche en Santé 2 Nantes Biotech, Service d'Anesthésie Réanimation chirurgicale, Hôtel Dieu, Nantes, France.
  • Becher B; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. Electronic address: becher@immunology.uzh.ch.
J Allergy Clin Immunol ; 150(2): 312-324, 2022 08.
Article em En | MEDLINE | ID: mdl-35716951
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Insuficiência Renal Crônica / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Insuficiência Renal Crônica / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2022 Tipo de documento: Article